About this employer
Organization details and candidate context.
Recent openings
Newest live roles published by this organization.
About this employer
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation. Avalo’s lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. For more information about Avalo, please visit www.avalotx.com. Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
Recent openings
Newest live roles published by this organization.
Hiring locations
Browse active openings by city.
Similar hiring organizations
Explore organizations with active openings in the same hiring market.
Follow employer
Follow this employer to get notified when new openings are posted.
